PFIZER INC.CDR REG.S

PFIZER INC.CDR REG.S

Share · CA7170651060 · A3DDVB (NEOE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PFIZER INC.CDR REG.S
No Price
29.04.2026 16:21
Current Prices from PFIZER INC.CDR REG.S
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
PIRSCD60.DUSD
EUR
29.04.2026 16:21
7,60 EUR
-0,10 EUR
-1,30 %
XDUS: Düsseldorf
Düsseldorf
PIRSCD60.DUSB
EUR
28.04.2026 17:31
7,25 EUR
-0,45 EUR
-5,84 %
Company Profile for PFIZER INC.CDR REG.S Share
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Company Data

Name PFIZER INC.CDR REG.S
Company Pfizer Inc.
Website https://www.pfizer.com
Primary Exchange NEOE Frankfurt
WKN A3DDVB
ISIN CA7170651060
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Albert Bourla
Market Capitalization 191 Mrd.
Country United States of America
Currency EUR
Employees 81,0 T
Address 66 Hudson Boulevard East, 10001-2192 New York City
IPO Date 2021-12-01
Dividends from 'PFIZER INC.CDR REG.S'
Ex-Date Dividend per Share
07.11.2025 0,19 CAD

Ticker Symbols

Name Symbol
Düsseldorf PIRSCD60.DUSB
Frankfurt PFEB.F
Quotrix PIRSCD60.DUSD
More Shares
Investors who hold PFIZER INC.CDR REG.S also have the following shares in their portfolio:
ACEF HOLDING 21/28 MTN
ACEF HOLDING 21/28 MTN Bond
Panacea Biotec Limited
Panacea Biotec Limited Share